Novartis AG

(NVS) Trade

By |

Profile

Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total sales.

Contact Information

Website: www.novartis.com
Email: Investor.relations@novartis.com
Main Phone: +41 613241111
Address: Lichtstrasse 35
City / Town: Basel
Country: CHE
Postal Code: 4056

Issuer Information

Exchange: NYE
CEO: Vasant Narasimhan
Employees: 125161
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total sales.

Contact Information

Website: www.novartis.com
Email: Investor.relations@novartis.com
Main Phone: +41 613241111
Address: Lichtstrasse 35
City / Town: Basel
Country: CHE
Postal Code: 4056

Issuer Information

Exchange: NYE
CEO: Vasant Narasimhan
Employees: 125161
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 91.46 $ 1.70 (1.89%)
Last Price 91.46 Change $ 1.70 Change % 1.89 Tick N/A
Bid 91.45 Bid Size 200.00 Ask 91.47 Ask Size 200.00
Open 91.31 High 91.63 Low 90.98 Prev Close 89.76
Last Trade Volume 1.8 mi 52 Wk Hi 96.31 52 Wk Low 72.30
Market Cap 209.8 bi Ex-Div Date Div Rate 2.83 Yield 3.1570
Shares 2,294,294,820.00 EPS (TTM) 5.28 PE Ratio 17.00 Exchange NYSE
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 98 98 98 98
Low Target Price Estimate 82.3 82.3 82.3 82.3
Mean Target Price Estimate 90.77 90.77 90.77 90.15
Standard Deviation 7.92 7.92 7.92 11.1
Date of Most Recent Estimate 04/23/18 04/23/18 04/23/18 04/23/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 1
Mean Rec. 2.8 2.8 2.8 2.5